{
    "organizations": [],
    "uuid": "8e9e46601d5fdd3f30ef3bd4cbda7bde9237f144",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-nextcell-enters-into-memorandum-of/brief-nextcell-enters-into-memorandum-of-agreement-with-china-general-consulting-investment-co-idUSFWN1S40I6",
    "ord_in_thread": 0,
    "title": "BRIEF-Nextcell Enters Into Memorandum Of Agreement With China General Consulting & Investment Co",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 27 (Reuters) - NEXTCELL PHARMA AB:\n* NEXTCELL ENTERS INTO MEMORANDUM OF AGREEMENT WITH CHINA GENERAL CONSULTING & INVESTMENT CO., LTD.\n* MEMORANDUM OF AGREEMENT IS TO BE DESIGNATED AS A DECLARATION OF INTENT WITHOUT OBLIGATION\n* AGREEMENT IS VALID UNTIL FURTHER NOTICE. Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-27T14:28:00.000+03:00",
    "crawled": "2018-04-28T12:42:55.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "nextcell",
        "pharma",
        "ab",
        "nextcell",
        "enters",
        "memorandum",
        "agreement",
        "china",
        "general",
        "consulting",
        "investment",
        "memorandum",
        "agreement",
        "designated",
        "declaration",
        "intent",
        "without",
        "obligation",
        "agreement",
        "valid",
        "notice",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}